ResMed Debuts AirTouch N20 Foam CPAP Mask, Its Softest Nasal Mask Ever
01 Septiembre 2020 - 08:00AM
Business Wire
- ResMed’s first nasal memory foam cushion enhances patients’
comfort and convenience, doesn’t need cleaning when replaced on an
appropriate schedule
- AirTouch N20 is the latest offering in ResMed’s line of
easy-to-use, convenient, and more comfortable masks
ResMed (NYSE: RMD, ASX: RMD) announced today the launch of its
AirTouch N20 nasal mask, the company’s first CPAP nasal mask with a
memory foam cushion and softest nasal mask ever.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20200901005249/en/
ResMed AirTouch N20, nasal CPAP mask with
UltraSoft memory foam cushion (Photo: Business Wire)
AirTouch N20 uses the same patented UltraSoft memory foam
cushion as the full face AirTouch F20 mask introduced in 2017. Both
adapt to the curves and contours of each face, creating a soft,
personalized fit designed to increase comfort and CPAP adherence.
In a clinical study, 90 percent of CPAP users gave the UltraSoft
foam cushion a high rating for comfort – a 4 or 5 out of 5.1
This unique comfort also comes with added convenience: The foam
cushion doesn’t require cleaning when replaced on an appropriate
schedule.
Most important, AirTouch N20’s comfort and convenience can help
increase patient satisfaction, adherence, and benefit from
long-term therapy.
Additional features include:
- Quick-release elbow allows patients to easily disconnect from
tubing without removing their mask, and magnetic clips guide the
headgear to the frame quickly and easily
- AirFit N20’s mask frame fits both AirFit N20 silicone and
AirTouch N20 memory foam cushions, allowing clinicians to
conveniently switch between the two during fittings or send
patients home with both to see which cushion type they prefer
- A seal designed for therapy pressures up to 30 cm H2O
“CPAP therapy should be simple, comfortable, and easy to use –
and AirTouch N20 delivers on all three,” said Jim Hollingshead,
ResMed president of Sleep and Respiratory Care. “The foam cushion
is uniquely comfortable, adapts to give everyone a personalized
fit, and doesn’t need cleaning. It’s ideal for nasal CPAP users and
their providers.”
AirTouch N20 is the latest in ResMed’s family of innovative CPAP
masks, connected devices, and digital health technologies for
helping millions with sleep apnea, COPD, and other chronic diseases
sleep, breathe, and live better.
AirTouch N20 is now available in the U.S., Canada, and most of
Europe, with Asia-Pacific launches planned for later this year. For
more information, visit ResMed.com/AirTouchN20.
About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions
that treat and keep people out of the hospital, empowering them to
live healthier, higher-quality lives. Our digital health
technologies and cloud-connected medical devices transform care for
people with sleep apnea, COPD, and other chronic diseases. Our
comprehensive out-of-hospital software platforms support the
professionals and caregivers who help people stay healthy in the
home or care setting of their choice. By enabling better care, we
improve quality of life, reduce the impact of chronic disease, and
lower costs for consumers and healthcare systems in more than 140
countries. To learn more, visit ResMed.com and follow @ResMed.
1 ResMed clinical study: ResMed AirTouch F20 full face mask
evaluation of facial marks. A total of 29 evaluable CPAP users
trialed the mask at home for 30 nights in place of their current
mask in which they were experiencing facial marks. Conducted from
September 11, 2017 to February 19, 2018. (AirTouch N20 uses the
same UltraSoft™ memory foam cushion technology as AirTouch
F20).
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200901005249/en/
For media Jayme Rubenstein +1 858.836.6798
news@resmed.com
For investors Amy Wakeham +1 858.836.5000
investorrelations@resmed.com
Resmed (ASX:RMD)
Gráfica de Acción Histórica
De Feb 2024 a Mar 2024
Resmed (ASX:RMD)
Gráfica de Acción Histórica
De Mar 2023 a Mar 2024